Posted in | News | Business | Electronics

Synopsys Strengthens ASIP Tools Portfolio with Target Compiler Technologies Acquisition

Synopsys, Inc., a global leader providing software, IP and services used to accelerate innovation in chips and electronic systems, today announced it has completed the acquisition of Target Compiler Technologies, a privately held company headquartered in Leuven, Belgium, that provides software tools to design and program application-specific instruction-set processors (ASIPs).

ASIPs complement industry-standard processor architectures by enabling designers to implement their own highly specialized software programmable engines for compute-intensive digital signal and data plane processing. The acquisition of Target strengthens Synopsys' existing ASIP tools portfolio while bringing a world-class team of ASIP experts into the company.

"As today's SoCs rely more on heterogeneous multi-core architectures, designers are turning to ASIPs to implement their unique data plane and digital signal processing requirements," said John Koeter, vice president of marketing of IP and Systems at Synopsys. "Target's leading IP Designer and MP Designer software tools perfectly complement Synopsys' offerings for ASIP developers, enabling design teams to develop ASIPs that meet their performance, power, and flexibility requirements more efficiently and with less risk."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.